Exploring the impact of metabolic imaging in head and neck cancer treatment

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Background

Target volume delineation is performed with anatomical imaging for head and neck cancer. Molecular imaging allows the recognition of specific tumor regions. Its inclusion in the pathway could lead to changes in delineation and resultant treatment plans.

Methods

PRISMA methodology was adhered to when selecting the articles for analysis and only full articles were quality assessed.

Results

Seventeen articles were included. Gross tumor volume (GTV) primary, GTV nodal, and other target volumes were evaluated. Positron emission tomography/computerized tomography (PET/CT) produced smaller primary GTVs, although not with diffusion‐weighted imaging‐magnetic resonance imaging (DWI‐MRI) or PET/MRI. The impact of these image modalities on GTV nodal did not display any consistency. Additionally, there was considerable heterogeneity in metrics comparing delineations. Four studies included appraised the dosimetric impact of the changes in target volume delineation.

Conclusion

Quantifying the impact of molecular imaging is difficult, due to heterogeneity in reporting metrics in molecular imaging modalities and a paucity of detail regarding delineation method and guideline adherence.

Related collections

Most cited references 43

Record: found
Abstract: found
Article: not found

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

Alessandro Liberati, Douglas G. Altman, Jennifer Tetzlaff … (2010)

Systematic reviews and meta-analyses are essential to summarise evidence relating to efficacy and safety of healthcare interventions accurately and reliably. The clarity and transparency of these reports, however, are not optimal. Poor reporting of systematic reviews diminishes their value to clinicians, policy makers, and other users. Since the development of the QUOROM (quality of reporting of meta-analysis) statement—a reporting guideline published in 1999—there have been several conceptual, methodological, and practical advances regarding the conduct and reporting of systematic reviews and meta-analyses. Also, reviews of published systematic reviews have found that key information about these studies is often poorly reported. Realising these issues, an international group that included experienced authors and methodologists developed PRISMA (preferred reporting items for systematic reviews and meta-analyses) as an evolution of the original QUOROM guideline for systematic reviews and meta-analyses of evaluations of health care interventions. The PRISMA statement consists of a 27-item checklist and a four-phase flow diagram. The checklist includes items deemed essential for transparent reporting of a systematic review. In this explanation and elaboration document, we explain the meaning and rationale for each checklist item. For each item, we include an example of good reporting and, where possible, references to relevant empirical studies and methodological literature. The PRISMA statement, this document, and the associated website (www.prisma-statement.org/) should be helpful resources to improve reporting of systematic reviews and meta-analyses.

0 comments Cited 3496 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual.

William M Lydiatt, Snehal Patel, Brian O'Sullivan … (2017)

Answer questions and earn CME/CNE The recently released eighth edition of the American Joint Committee on Cancer (AJCC) Staging Manual, Head and Neck Section, introduces significant modifications from the prior seventh edition. This article details several of the most significant modifications, and the rationale for the revisions, to alert the reader to evolution of the field. The most significant update creates a separate staging algorithm for high-risk human papillomavirus-associated cancer of the oropharynx, distinguishing it from oropharyngeal cancer with other causes. Other modifications include: the reorganizing of skin cancer (other than melanoma and Merkel cell carcinoma) from a general chapter for the entire body to a head and neck-specific cutaneous malignancies chapter; division of cancer of the pharynx into 3 separate chapters; changes to the tumor (T) categories for oral cavity, skin, and nasopharynx; and the addition of extranodal cancer extension to lymph node category (N) in all but the viral-related cancers and mucosal melanoma. The Head and Neck Task Force worked with colleagues around the world to derive a staging system that reflects ongoing changes in head and neck oncology; it remains user friendly and consistent with the traditional tumor, lymph node, metastasis (TNM) staging paradigm. CA Cancer J Clin 2017;67:122-137. © 2017 American Cancer Society.

0 comments Cited 410 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

David Pfister, Sharon Spencer, David L. Adelstein … (2020)

Treatment is complex for patients with head and neck (H&N) cancers with specific site of disease, stage, and pathologic findings guiding treatment decision-making. Treatment planning for H&N cancers involves a multidisciplinary team of experts. This article describes supportive care recommendations in the NCCN Guidelines for Head and Neck Cancers, as well as the rationale supporting a new section on imaging recommendations for patients with H&N cancers. This article also describes updates to treatment recommendations for patients with very advanced H&N cancers and salivary gland tumors, specifically systemic therapy recommendations.

0 comments Cited 267 times – based on 0 reviews      Review now

Bookmark

All references

Author and article information

Contributors

Diana Raquel Dias Domingues:

ORCID: https://orcid.org/0000-0001-7799-8428

diasdomd@tcd.ie , ddiasdomingues@gmail.com , ddiasdomingues@gmail.com , ddiasdomingues@gmail.com

Journal

Journal ID (nlm-ta): Head Neck

Journal ID (iso-abbrev): Head Neck

Journal ID (doi): 10.1002/(ISSN)1097-0347

Journal ID (publisher-id): HED

Title: Head & Neck

Publisher: John Wiley & Sons, Inc. (Hoboken, USA )

ISSN (Print): 1043-3074

ISSN (Electronic): 1097-0347

Publication date (Electronic): 01 July 2022

Publication date (Print): October 2022

Volume: 44

Issue: 10 ( doiID: 10.1002/hed.v44.10 )

Pages: 2228-2247

Affiliations

[ ¹ ] Cambridge University Hospitals NHS Trust Cambridge UK

[ ² ] Trinity College Dublin Dublin Ireland

Author notes

[*] [* ] Correspondence

Diana Raquel Dias Domingues, Cambridge University Hospitals NHS Trust, 16 Hartree Lane, Trumpington, Cambridge CB2 9EQ, UK.

Email: diasdomd@ 123456tcd.ie or

Email: ddiasdomingues@ 123456gmail.com

Author information

Diana Raquel Dias Domingues https://orcid.org/0000-0001-7799-8428

Article

Publisher ID: HED27131

DOI: 10.1002/hed.27131

PMC ID: 9545005

PubMed ID: 35775713

SO-VID: 5a170e94-c9d6-4dca-9556-4a6b1222c454

License:

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

History

Date revision received : 09 June 2022

Date received : 09 February 2022

Date accepted : 16 June 2022

Page count

Figures: 3, Tables: 6, Pages: 20, Words: 11095

Custom metadata

source-schema-version-number 2.0

cover-date October 2022

details-of-publishers-convertor Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.0 mode:remove_FC converted:07.10.2022

ScienceOpen disciplines: Otolaryngology

Keywords: delineation,head and neck,imaging,metabolic,radiotherapy

Data availability:

ScienceOpen disciplines: Otolaryngology

Keywords: delineation, head and neck, imaging, metabolic, radiotherapy

Exploring the impact of metabolic imaging in head and neck cancer treatment

Read this article at

Abstract

Background

Methods

Results

Conclusion

Related collections

Electron Channelling Contrast Imaging (ECCI)

Most cited references 43

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual.

Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

Author and article information

Contributors

Journal

Affiliations

Author notes

Author information

Article

History

Page count

Categories

Custom metadata

Comments

Comment on this article

Similar content 245

Most referenced authors 694